483 filings
Page 17 of 25
8-K/A
MYMD
MyMD Pharmaceuticals Inc
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
3
Christopher C Schreiber
21 Sep 18
Akers Biosciences / Christopher C Schreiber ownership change
4:50pm
3
Silverman Joshua
20 Sep 18
Akers Biosciences / Joshua Silverman ownership change
3:40pm
8-K
MYMD
MyMD Pharmaceuticals Inc
11 Sep 18
Departure of Directors or Certain Officers
12:00am
10-Q
2018 Q2
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
14 Aug 18
4:34pm
SC 13G/A
MYMD
MyMD Pharmaceuticals Inc
26 Jul 18
Akers Biosciences, Inc.
4:08pm
10-Q
2018 Q1
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
13 Jul 18
4:27pm
10-K/A
2017 FY
MYMD
MyMD Pharmaceuticals Inc
Annual report (amended)
13 Jul 18
4:23pm
8-K
MYMD
MyMD Pharmaceuticals Inc
19 Jun 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:20pm
8-K
MYMD
MyMD Pharmaceuticals Inc
15 Jun 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K/A
MYMD
MyMD Pharmaceuticals Inc
5 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
1 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
MYMD
MyMD Pharmaceuticals Inc
25 May 18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
5:00pm
8-K
MYMD
MyMD Pharmaceuticals Inc
21 May 18
Other Events
5:20pm
NT 10-Q
MYMD
MyMD Pharmaceuticals Inc
16 May 18
Notice of late quarterly filing
5:22pm
SC 13G/A
MYMD
MyMD Pharmaceuticals Inc
7 May 18
Akers Biosciences, Inc.
5:02pm